Literature DB >> 7775179

Dopamine hypersensitivity in migraine: role in apomorphine syncope.

M Del Zompo1, M Lai, V Loi, M R Pisano.   

Abstract

There is some evidence supporting a potential role of hypersensitivity of the dopaminergic system in the pathogenesis of migraine. In this case report, we describe a syncopal episode in a patient with migraine without aura after the administration of a very low dose of apomorphine, a classical agonist of dopaminergic receptors. The absence of cardiovascular risk factors in this patient suggests that the clinical event might have been caused by hypersensitivity of the dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775179     DOI: 10.1111/j.1526-4610.1995.hed3504222.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

1.  Use of dopamine antagonists in treatment of migraine.

Authors:  Michael J Marmura
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

2.  Hypothalamic regulation of headache and migraine.

Authors:  Arne May; Rami Burstein
Journal:  Cephalalgia       Date:  2019-08-29       Impact factor: 6.292

Review 3.  Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging.

Authors:  Arne May
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 4.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

5.  Headaches from cellular telephones: are they real and what are the implications?

Authors:  A H Frey
Journal:  Environ Health Perspect       Date:  1998-03       Impact factor: 9.031

6.  Serum prolactin and migraine.

Authors:  S Ali Masoud; E Fakharian
Journal:  Ann Saudi Med       Date:  2005 Nov-Dec       Impact factor: 1.526

7.  Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition.

Authors:  Cenk Ayata; Hayrunnisa Bolay; Doga Vuralli; Burak Arslan; Elif Topa; Andreia Lopes de Morais; Ozlem Gulbahar
Journal:  J Headache Pain       Date:  2022-03-14       Impact factor: 7.277

Review 8.  Acute treatment of migraine. Breaking the paradigm of monotherapy.

Authors:  Abouch Valenty Krymchantowski
Journal:  BMC Neurol       Date:  2004-01-28       Impact factor: 2.474

9.  Mobile Phone Use and The Risk of Headache: A Systematic Review and Meta-analysis of Cross-sectional Studies.

Authors:  Jing Wang; Hui Su; Wei Xie; Shengyuan Yu
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.